Baxter makes executive appointment
This article was originally published in Scrip
Executive Summary
Baxter International (US) has appointed Dr Ludwig Hantson corporate vice-president and president, international, effective 3 May. Dr Hantson has served in several senior management positions at Novartis since 2001, most recently as CEO of pharma North America at Novartis Pharmaceuticals. Before Novartis, he spent 13 years at Janssen Pharmaceutica working in marketing and clinical R&D.